Overview
XTNT market data
Price History
XTNT price chart · 1M
- O
- 0.320900
- H
- 0.322900
- L
- 0.320900
- C
- 0.322900
- Vol
- 2,696.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $0.32
- Previous Close
- $0.34
- Day High
- $0.32
- Day Low
- $0.32
- 52 Week High
- $0.66
- 52 Week Low
- $0.28
- 7 Day Return
- -4.58%
- 30 Day Return
- -24.31%
- 90 Day Return
- -32.04%
- 1 Year Return
- -49.34%
- Daily Notional Volume
- $870.5 Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 23.84 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.03 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 1.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.27 – $0.95 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $43.5M · P/B 2.15 · P/S 0.36.
Company News
Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private BrandBenzinga · Aug 27, 2026, 12:10 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 11, 2026, 5:06 PM
Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance.Benzinga · Aug 11, 2026, 1:11 PM
8-K filing — Xtant Medical Holdings, Inc. (XTNT)SEC EDGAR · Aug 11, 2026, 11:05 AM
Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M EstimateBenzinga · Aug 11, 2026, 11:03 AM
Xtant Medical Hldgs Lowers FY2026 Sales Guidance from $101.000M-$105.000M to $99.000M-$103.000M vs $102.058M EstBenzinga · Aug 11, 2026, 11:01 AM